Literature DB >> 15509658

ApoE-mediated cholesterol efflux from macrophages: separation of autocrine and paracrine effects.

Dwayne E Dove1, Macrae F Linton, Sergio Fazio.   

Abstract

Macrophages in the vessel wall secrete high levels of apolipoprotein E (apoE). Cholesterol efflux from macrophages to apoE has been shown to decrease foam cell formation and prevent atherosclerosis. An apoE molecule can mediate cholesterol efflux from the macrophage that originally secreted it (autocrine effect) or from surrounding macrophages (paracrine effect). Traditional methodologies have not been able to separate these serial effects. The novel methodology presented here was developed to separate autocrine and paracrine effects by using a simple mathematical model to interpret the effects of dilution on apoE-mediated cholesterol efflux. Our results show that, at very dilute concentrations, the paracrine effect of apoE is not evident and the autocrine effect becomes the dominant mediator of efflux. However, at saturating concentrations, paracrine apoE causes 80-90% of the apoE-mediated cholesterol efflux, whereas autocrine apoE is responsible for the remaining 10-20%. These results suggest that the relative importance of autocrine and paracrine apoE depends on the size of the local distribution volume, a factor not considered in previous in vitro studies of apoE function. Furthermore, autocrine effects of apoE could be critical in the prevention of foam cell formation in vivo. This novel methodology may be applicable to other types of mixed autocrine/paracrine systems, such as signal transduction systems.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15509658     DOI: 10.1152/ajpcell.00210.2004

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  12 in total

Review 1.  Paracrinicity: the story of 30 years of cellular pituitary crosstalk.

Authors:  C Denef
Journal:  J Neuroendocrinol       Date:  2008-01       Impact factor: 3.627

2.  Macrophage apoAI protects against dyslipidemia-induced dermatitis and atherosclerosis without affecting HDL.

Authors:  Hagai Tavori; Yan Ru Su; Patricia G Yancey; Ilaria Giunzioni; Ashley J Wilhelm; John L Blakemore; Manal Zabalawi; MacRae F Linton; Mary G Sorci-Thomas; Sergio Fazio
Journal:  J Lipid Res       Date:  2015-01-15       Impact factor: 5.922

3.  LXR agonist treatment of blastic plasmacytoid dendritic cell neoplasm restores cholesterol efflux and triggers apoptosis.

Authors:  Adam Ceroi; David Masson; Anne Roggy; Christophe Roumier; Cécile Chagué; Thierry Gauthier; Laure Philippe; Baptiste Lamarthée; Fanny Angelot-Delettre; Francis Bonnefoy; Sylvain Perruche; Sabeha Biichle; Claude Preudhomme; Elisabeth Macintyre; Laurent Lagrost; Francine Garnache-Ottou; Philippe Saas
Journal:  Blood       Date:  2016-10-04       Impact factor: 22.113

4.  Cholesterol and matrisome pathways dysregulated in astrocytes and microglia.

Authors:  Julia Tcw; Lu Qian; Nina H Pipalia; Michael J Chao; Shuang A Liang; Yang Shi; Bharat R Jain; Sarah E Bertelsen; Manav Kapoor; Edoardo Marcora; Elizabeth Sikora; Elizabeth J Andrews; Alessandra C Martini; Celeste M Karch; Elizabeth Head; David M Holtzman; Bin Zhang; Minghui Wang; Frederick R Maxfield; Wayne W Poon; Alison M Goate
Journal:  Cell       Date:  2022-06-23       Impact factor: 66.850

5.  Analysis of inflammatory and lipid metabolic networks across RAW264.7 and thioglycolate-elicited macrophages.

Authors:  Mano R Maurya; Shakti Gupta; Xiang Li; Eoin Fahy; Ashok R Dinasarapu; Manish Sud; H Alex Brown; Christopher K Glass; Robert C Murphy; David W Russell; Edward A Dennis; Shankar Subramaniam
Journal:  J Lipid Res       Date:  2013-06-17       Impact factor: 5.922

6.  Modification by isolevuglandins, highly reactive γ-ketoaldehydes, deleteriously alters high-density lipoprotein structure and function.

Authors:  Linda S May-Zhang; Valery Yermalitsky; Jiansheng Huang; Tiffany Pleasent; Mark S Borja; Michael N Oda; W Gray Jerome; Patricia G Yancey; MacRae F Linton; Sean S Davies
Journal:  J Biol Chem       Date:  2018-04-30       Impact factor: 5.157

7.  A novel function of apolipoprotein E: upregulation of ATP-binding cassette transporter A1 expression.

Authors:  Yanfeng Zhao; Xinping Chen; Hong Yang; Lichun Zhou; Emmanuel U Okoro; Zhongmao Guo
Journal:  PLoS One       Date:  2011-07-11       Impact factor: 3.240

Review 8.  Apolipoprotein E - A Multifunctional Protein with Implications in Various Pathologies as a Result of Its Structural Features.

Authors:  Irina Florina Tudorache; Violeta Georgeta Trusca; Anca Violeta Gafencu
Journal:  Comput Struct Biotechnol J       Date:  2017-06-06       Impact factor: 7.271

Review 9.  Recent insights into the implications of metabolism in plasmacytoid dendritic cell innate functions: Potential ways to control these functions.

Authors:  Philippe Saas; Alexis Varin; Sylvain Perruche; Adam Ceroi
Journal:  F1000Res       Date:  2017-04-10

10.  Hepatocyte estrogen receptor alpha mediates estrogen action to promote reverse cholesterol transport during Western-type diet feeding.

Authors:  Lin Zhu; Jeanne Shi; Thao N Luu; Joshua C Neuman; Elijah Trefts; Sophia Yu; Brian T Palmisano; David H Wasserman; MacRae F Linton; John M Stafford
Journal:  Mol Metab       Date:  2017-12-29       Impact factor: 7.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.